Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06576869 · ClinicalTrials.gov registry record · NA
Timing of Tourniquet Release
A NA study, sponsored by Orlando Health.
- Completed
- Registry status
- NA
- Development phase
- 214
- Enrollment target
NCT06576869: Completed NA study, sponsored by Orlando Health.
NCT06576869 is a NA study that has completed, run by Orlando Health. The registered enrollment target is 214 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06576869, a NA study, has completed, sponsored by Orlando Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 214 participants
- Enrollment target
Study Summary
This will be a prospective randomized clinical trial comparing clinical outcome measures in patients who undergo elective upper extremity surgery when tourniquet is dropped prior to closure as opposed to when tourniquet is dropped after closure. The study will compare objective data obtained intraoperatively as well as standard clinical outcome measures such as pain scores at routine follow up.
Primary Outcome
Visual number scale to rate pain from 0-10 where 0 equals no pain and 10 equals worst possible pain
Interventions
- PROCEDURE Upper extremity orthopedic surgeries.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2022-06-02 |
| Est. Completion | 2023-05-09 |
| Phase | NA |
What the finished NCT06576869 record still lists
NCT06576869 is an interventional study that assigns participants to a tested intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which Upper extremity orthopedic surgeries. is the first listed.
NCT06576869 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06576869 about?
NCT06576869 is a clinical study titled "Timing of Tourniquet Release". This will be a prospective randomized clinical trial comparing clinical outcome measures in patients who undergo elective upper extremity surgery when tourniquet is dropped prior to closure as opposed to when tourniquet is dropped after closure. The study will compare objective data obtained intraop...
What is the current status of trial NCT06576869?
This trial is currently completed. It is a NA study. The enrollment target is 214 participants. The study started on 2022-06-02. Estimated completion is 2023-05-09.
What interventions are being tested in trial NCT06576869?
The interventions under investigation include: Upper extremity orthopedic surgeries. (PROCEDURE).
Who is sponsoring clinical trial NCT06576869?
This trial is sponsored by Orlando Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06576869's enrollment target sits among peer trials
214 487th of 2000 higher than 1,513 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT04667520 · 214 participants · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI